A detailed history of Johnson Investment Counsel Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 102,473 shares of MRK stock, worth $8.85 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
102,473
Previous 103,765 1.25%
Holding current value
$8.85 Million
Previous $11.8 Million 13.49%
% of portfolio
0.1%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

SELL
$96.31 - $114.76 $124,432 - $148,269
-1,292 Reduced 1.25%
102,473 $10.2 Million
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $725,476 - $841,787
6,527 Added 6.71%
103,765 $11.8 Million
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $137,294 - $147,452
-1,109 Reduced 1.13%
97,238 $12 Million
Q1 2024

May 09, 2024

SELL
$113.24 - $131.95 $113,806 - $132,609
-1,005 Reduced 1.01%
98,347 $13 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $212,481 - $231,231
2,121 Added 2.18%
99,352 $10.8 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $457,509 - $508,082
-4,444 Reduced 4.37%
97,231 $10 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $347,443 - $378,697
3,199 Added 3.25%
101,675 $11.7 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $105,204 - $117,386
-1,022 Reduced 1.03%
98,476 $10.5 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $108,163 - $138,680
-1,237 Reduced 1.23%
99,498 $11 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $114,030 - $128,101
-1,349 Reduced 1.32%
100,735 $8.68 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $203,548 - $230,732
2,438 Added 2.45%
102,084 $9.31 Million
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $874,842 - $980,642
11,901 Added 13.56%
99,646 $8.25 Million
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $40,115 - $50,249
555 Added 0.64%
87,745 $6.79 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $258,263 - $284,024
-3,603 Reduced 3.97%
87,190 $6.61 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $329,964 - $364,974
4,693 Added 5.45%
90,793 $7.12 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $228,821 - $269,528
3,323 Added 4.01%
86,100 $6.69 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $144,042 - $159,857
2,007 Added 2.48%
82,777 $6.83 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $184,267 - $208,868
-2,518 Reduced 3.02%
80,770 $6.75 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $342,945 - $390,233
-4,870 Reduced 5.52%
83,288 $6.49 Million
Q1 2020

May 20, 2020

SELL
$63.36 - $87.82 $100,679 - $139,545
-1,589 Reduced 1.77%
88,158 $6.84 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $143,212 - $161,598
-1,846 Reduced 2.02%
89,747 $8.22 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $4,716 - $5,141
62 Added 0.07%
91,593 $7.76 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $382,304 - $446,623
5,474 Added 6.36%
91,531 $7.67 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $166,296 - $189,670
2,390 Added 2.86%
86,057 $7.16 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $266,048 - $308,745
4,078 Added 5.12%
83,667 $6.39 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $354,908 - $417,351
6,152 Added 8.38%
79,589 $5.65 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $336,901 - $395,824
-6,628 Reduced 8.28%
73,437 $4.46 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $164,346 - $191,016
-3,225 Reduced 3.87%
80,065 $4.36 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $229,141 - $273,619
-4,439 Reduced 5.06%
83,290 $4.69 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $5.15 Million - $5.54 Million
87,729
87,729 $5.62 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $219B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.